Pricing Log in Create free account

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) vs Atrinsic Inc. (PTIX)

Biodexa Pharmaceuticals PLC Unsponsored ADR and Atrinsic Inc. are both Biotechnology companies. Biodexa Pharmaceuticals PLC Unsponsored ADR and Atrinsic Inc. are of similar size ($1.3M and $1.3M). Biodexa Pharmaceuticals PLC Unsponsored ADR has negative trailing earnings, so its P/E is not meaningful; Atrinsic Inc. trades at 0.2×. Atrinsic Inc. has the higher net margin (0.00% vs −1,155.7%) and the lower return on invested capital (−229.9% vs 0.00%). Across the 9 metrics below, Atrinsic Inc. leads on 5 and Biodexa Pharmaceuticals PLC Unsponsored ADR on 4.

Valuation

Metric BDRX PTIX Biotechnology median
P/E n/m 0.24 10.60
P/S n/m n/m 9.40
P/B n/m 0.57 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.20 n/m 0.66
EV/Sales (2.81) n/m 9.02
Earnings yield (102.95%) 412.96% (32.88%)
Free cash flow yield 0.00% (220.47%) (23.13%)

Profitability

Metric BDRX PTIX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin (1,155.70%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (338.24%) (51.96%)
Return on assets 0.00% 378.63% (46.06%)
Return on invested capital 0.00% (229.86%) 0.00%

Growth

Metric BDRX PTIX Biotechnology median
Revenue growth (TTM) 60.22% — 6.76%
EPS growth (last fiscal year) 89.62% 188.24% 29.88%
Revenue growth, 5-year CAGR (28.78%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDRX PTIX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.41 0.66 4.97
Net debt to EBITDA 1.00 0.52 1.01

Dividend

Metric BDRX PTIX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BDRX PTIX Biotechnology median
Market cap 1.25m 1.27m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack